[{"notes_id":"1_1008","category":"10","subcategory":"2","title":"Benign prostatic hyperplasia","body":"Benign prostatic hyperplasia (BPH) is a common condition seen in older men. <br \/><br \/>Risk factors<br \/><ul><li>age<ul><li>around 50% of 50-year-old men will have evidence of BPH and 30% will have symptoms<\/li><li>around 80% of 80-year-old men have evidence of BPH<\/li><\/ul><\/li><li>ethnicity: black > white > Asian<\/li><\/ul><br \/>BPH typically presents with lower urinary tract symptoms (LUTS), which may be categorised into:<br \/><ul><li>voiding symptoms (obstructive): <ul><li>weak or intermittent urinary flow<\/li><li>straining<\/li><li>hesitancy<\/li><li>terminal dribbling<\/li><li>incomplete emptying<\/li><\/ul><\/li><li>storage symptoms (irritative)<ul><li>urgency<\/li><li>frequency<\/li><li>urgency incontinence<\/li><li>nocturia<\/li><\/ul><\/li><li>post-micturition<ul><li>dribbling<\/li><\/ul><\/li><li>complications<ul><li>urinary tract infection<\/li><li>retention<\/li><li>obstructive uropathy<\/li><\/ul><\/li><\/ul><br \/>Assessment<br \/><ul><li>dipstick urine<\/li><li>U&Es: particularly if chronic retention is suspected<\/li><li>PSA: should be done if there are any obstructive symptoms, of if the patient is worried about prostate cancer<\/li><li> urinary frequency-volume chart<ul><li>should be done for at least 3 days<\/li><\/ul><\/li><li>International Prostate Symptom Score (IPSS)<ul><li> tool for classifying the severity of lower urinary tract symptoms (LUTS) and assessing the impact of LUTS on quality of life<\/li><li>Score 20-35: severely symptomatic<\/li><li>Score 8-19: moderately symptomatic<\/li><li>Score 0-7: mildly symptomatic<\/li><\/ul><\/li><\/ul><br \/>Management options<br \/><ul><li>watchful waiting<\/li><li>alpha-1 antagonists  e.g. tamsulosin, alfuzosin<ul><li><span class=\"concept\" data-cid=\"2252\">decrease smooth muscle tone  of the prostate and bladder<\/span><\/li><li><span class=\"concept\" data-cid=\"11504\">considered first-line<\/span>: NICE recommend if moderate-to-severe voiding symptoms (IPSS \u2265 8)<\/li><li>improve symptoms in around 70% of men<\/li><li>adverse effects: dizziness, postural hypotension, dry mouth, depression<\/li><\/ul><\/li><li>5 alpha-reductase inhibitors  e.g. finasteride<ul><li>block the conversion of testosterone to dihydrotestosterone (DHT), which is known to induce BPH<\/li><li><span class=\"concept\" data-cid=\"11505\">indicated if the patient has a significantly enlarged prostate and is considered to be at high risk of progression<\/span><\/li><li>unlike alpha-1 antagonists causes a reduction in prostate volume and hence may slow disease progression. This however takes time and symptoms may not improve for <span class=\"concept\" data-cid=\"147\">6 months<\/span><\/li><li>may also decrease PSA concentrations by up to 50%<\/li><li>adverse effects: erectile dysfunction, reduced libido, ejaculation problems, gynaecomastia<\/li><\/ul><\/li><li>the use of <span class=\"concept\" data-cid=\"11506\">combination therapy<\/span> (alpha-1 antagonist +  5 alpha-reductase inhibitor) was supported by the Medical Therapy Of Prostatic Symptoms (MTOPS) trial and is also supported by NICE: '<i>If the man has bothersome moderate-to-severe voiding symptoms and prostatic enlargement<\/i>'<\/li><li>if there is a <span class=\"concept\" data-cid=\"11507\">mixture of storage symptoms and voiding symptoms<\/span> that persist after treatment with an alpha-blocker alone, then an antimuscarinic (anticholinergic) drug such as tolterodine or darifenacin may be tried<\/li><li>surgery<ul><li>transurethral resection of prostate (TURP)<\/li><\/ul><\/li><\/ul>","notes_hash":"2f6a46757c1acf59f32eb15b1f99ae6f","knowledge_graph_node_id_link":1074,"links":"<table style='width:100%'><tr><td>NICE<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_735\" data-linkid=\"735\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_735\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">10<\/span><button type=\"button\" style=\"\" id=\"link_dislike_735\" data-linkid=\"735\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_735\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.nice.org.uk\/guidance\/CG97\/chapter\/1-Recommendations\">2010 The management of lower urinary tract symptoms in men<\/a><\/td><\/tr><\/table>","media":"<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/ifGWIIKHGrU\" data-description=\"Benign prostatic hyperplasia \" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"868\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/ifGWIIKHGrU\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/ifGWIIKHGrU\" data-description=\"Benign prostatic hyperplasia \" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"868\">Benign prostatic hyperplasia <\/a><\/td><\/tr><tr><td><span ><small>Osmosis - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1518\" data-mediaid=\"1518\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_1518\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1<\/span><button type=\"button\" style=\"\" id=\"media_dislike_1518\" data-mediaid=\"1518\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_1518\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2<\/span><\/td><\/tr><\/table>","concepts_for_notes":{"147":{"concept_text":"Finasteride treatment of BPH may take 6 months before results are seen","concept_percentile":"79"}},"category_name":"Renal \/ Urology","subcategory_name":"Urology","comment_count":7},"",[]]